Commentary

Launch of a quality improvement network for evidence-based management of uncommon pediatric endocrine disorders: Turner syndrome as a prototype

Robert L. Rosenfield, Linda DiMeglio, Nelly Mauras, Judith Ross, Natalie D. Shaw, Siri A W Greeley, Morey Haymond, Karen Rubin, Erinn T. Rhodes

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Traditional, hypothesis-oriented research approaches have thus far failed to generate sufficient evidence to achieve consensus about the management of children with many endocrine disorders, partly because of the rarity of these disorders and because of regulatory burdens unique to research in children. Objective: The Pediatric Endocrine Society is launching a quality improvement network in spring 2015 for the management of pediatric endocrine disorders that are relatively uncommon in any single practice and/or for which there is no consensus on management. Design: The first of the quality improvement programs to be implemented seeks to improve the care of 11- to 17-year-old girls with Turner syndrome who require initiation of estrogen replacement therapy by providing a standardized clinical assessment and management plan (SCAMP) for transdermal estradiol treatment to induce pubertal development. The SCAM Palgorithm representsastarting point within current best practice that is meant to undergo refinement through an iterative process of analysis of deidentified data collected in the course of clinical care by a network of pediatric endocrinologists. Conclusion: It is anticipated that this program will not only improve care, but will also result in actionable data that will generate new research hypotheses and changes in management of pediatric endocrine disorders.

Original languageEnglish (US)
Pages (from-to)1234-1236
Number of pages3
JournalJournal of Clinical Endocrinology and Metabolism
Volume100
Issue number4
DOIs
StatePublished - Apr 1 2015

Fingerprint

Turner Syndrome
Pediatrics
Quality Improvement
Research
Estrogen Replacement Therapy
Practice Guidelines
Launching
Estradiol
Estrogens
Therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Commentary : Launch of a quality improvement network for evidence-based management of uncommon pediatric endocrine disorders: Turner syndrome as a prototype. / Rosenfield, Robert L.; DiMeglio, Linda; Mauras, Nelly; Ross, Judith; Shaw, Natalie D.; Greeley, Siri A W; Haymond, Morey; Rubin, Karen; Rhodes, Erinn T.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 100, No. 4, 01.04.2015, p. 1234-1236.

Research output: Contribution to journalArticle

Rosenfield, Robert L. ; DiMeglio, Linda ; Mauras, Nelly ; Ross, Judith ; Shaw, Natalie D. ; Greeley, Siri A W ; Haymond, Morey ; Rubin, Karen ; Rhodes, Erinn T. / Commentary : Launch of a quality improvement network for evidence-based management of uncommon pediatric endocrine disorders: Turner syndrome as a prototype. In: Journal of Clinical Endocrinology and Metabolism. 2015 ; Vol. 100, No. 4. pp. 1234-1236.
@article{b0120a73bc0041cc81dc25e650c785c4,
title = "Commentary: Launch of a quality improvement network for evidence-based management of uncommon pediatric endocrine disorders: Turner syndrome as a prototype",
abstract = "Background: Traditional, hypothesis-oriented research approaches have thus far failed to generate sufficient evidence to achieve consensus about the management of children with many endocrine disorders, partly because of the rarity of these disorders and because of regulatory burdens unique to research in children. Objective: The Pediatric Endocrine Society is launching a quality improvement network in spring 2015 for the management of pediatric endocrine disorders that are relatively uncommon in any single practice and/or for which there is no consensus on management. Design: The first of the quality improvement programs to be implemented seeks to improve the care of 11- to 17-year-old girls with Turner syndrome who require initiation of estrogen replacement therapy by providing a standardized clinical assessment and management plan (SCAMP) for transdermal estradiol treatment to induce pubertal development. The SCAM Palgorithm representsastarting point within current best practice that is meant to undergo refinement through an iterative process of analysis of deidentified data collected in the course of clinical care by a network of pediatric endocrinologists. Conclusion: It is anticipated that this program will not only improve care, but will also result in actionable data that will generate new research hypotheses and changes in management of pediatric endocrine disorders.",
author = "Rosenfield, {Robert L.} and Linda DiMeglio and Nelly Mauras and Judith Ross and Shaw, {Natalie D.} and Greeley, {Siri A W} and Morey Haymond and Karen Rubin and Rhodes, {Erinn T.}",
year = "2015",
month = "4",
day = "1",
doi = "10.1210/jc.2014-3845",
language = "English (US)",
volume = "100",
pages = "1234--1236",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Commentary

T2 - Launch of a quality improvement network for evidence-based management of uncommon pediatric endocrine disorders: Turner syndrome as a prototype

AU - Rosenfield, Robert L.

AU - DiMeglio, Linda

AU - Mauras, Nelly

AU - Ross, Judith

AU - Shaw, Natalie D.

AU - Greeley, Siri A W

AU - Haymond, Morey

AU - Rubin, Karen

AU - Rhodes, Erinn T.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Background: Traditional, hypothesis-oriented research approaches have thus far failed to generate sufficient evidence to achieve consensus about the management of children with many endocrine disorders, partly because of the rarity of these disorders and because of regulatory burdens unique to research in children. Objective: The Pediatric Endocrine Society is launching a quality improvement network in spring 2015 for the management of pediatric endocrine disorders that are relatively uncommon in any single practice and/or for which there is no consensus on management. Design: The first of the quality improvement programs to be implemented seeks to improve the care of 11- to 17-year-old girls with Turner syndrome who require initiation of estrogen replacement therapy by providing a standardized clinical assessment and management plan (SCAMP) for transdermal estradiol treatment to induce pubertal development. The SCAM Palgorithm representsastarting point within current best practice that is meant to undergo refinement through an iterative process of analysis of deidentified data collected in the course of clinical care by a network of pediatric endocrinologists. Conclusion: It is anticipated that this program will not only improve care, but will also result in actionable data that will generate new research hypotheses and changes in management of pediatric endocrine disorders.

AB - Background: Traditional, hypothesis-oriented research approaches have thus far failed to generate sufficient evidence to achieve consensus about the management of children with many endocrine disorders, partly because of the rarity of these disorders and because of regulatory burdens unique to research in children. Objective: The Pediatric Endocrine Society is launching a quality improvement network in spring 2015 for the management of pediatric endocrine disorders that are relatively uncommon in any single practice and/or for which there is no consensus on management. Design: The first of the quality improvement programs to be implemented seeks to improve the care of 11- to 17-year-old girls with Turner syndrome who require initiation of estrogen replacement therapy by providing a standardized clinical assessment and management plan (SCAMP) for transdermal estradiol treatment to induce pubertal development. The SCAM Palgorithm representsastarting point within current best practice that is meant to undergo refinement through an iterative process of analysis of deidentified data collected in the course of clinical care by a network of pediatric endocrinologists. Conclusion: It is anticipated that this program will not only improve care, but will also result in actionable data that will generate new research hypotheses and changes in management of pediatric endocrine disorders.

UR - http://www.scopus.com/inward/record.url?scp=84927620424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927620424&partnerID=8YFLogxK

U2 - 10.1210/jc.2014-3845

DO - 10.1210/jc.2014-3845

M3 - Article

VL - 100

SP - 1234

EP - 1236

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -